Repository logo
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Scholalry Output
  3. Publications
  4. Promising drug targets and associated therapeutic interventions in Parkinson's disease
 
  • Details

Promising drug targets and associated therapeutic interventions in Parkinson's disease

Source
Neural Regeneration Research
ISSN
16735374
Date Issued
2021-09-01
Author(s)
Rai, Sachchida Nand
Singh, Payal
Varshney, Ritu
Chaturvedi, Vivek K.
Vamanu, Emanuel
Singh, M. P.
Singh, Brijesh Kumar
DOI
10.4103/1673-5374.306066
Volume
16
Issue
9
Abstract
Parkinson's disease (PD) is one of the most debilitating brain diseases. Despite the availability of symptomatic treatments, response towards the health of PD patients remains scarce. To fulfil the medical needs of the PD patients, an efficacious and etiological treatment is required. In this review, we have compiled the information covering limitations of current therapeutic options in PD, novel drug targets for PD, and finally, the role of some critical beneficial natural products to control the progression of PD.
Publication link
https://doi.org/10.4103/1673-5374.306066
URI
https://d8.irins.org/handle/IITG2025/25324
Subjects
dopamine | epigenetics | gene therapies | glutamate receptor | levodopa | molecular chaperones | monoamine oxidase B | mucuna alpha-synuclein | Parkinson's disease | striatum | substantia nigra
IITGN Knowledge Repository Developed and Managed by Library

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify